Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Magnusson

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
European Journal of Heart Failure|October 28, 2024
Proteomic biomarkers and pathway analysis for progression to heart failure in three epidemiological representative cohortsAnna Dieden, Nicolas Girerd, Filip Ottosson, et al.
Nature Communications|May 22, 2015
Erratum: Distinct metabolomic signatures are associated with longevity in humansSusan Cheng, Martin G Larson, Elizabeth L McCabe, et al.
Circulation|April 13, 2012
Metabolite profiling identifies pathways associated with metabolic risk in humansSusan Cheng, Eugene P Rhee, Martin G Larson, et al.
Cardiovascular Research|May 6, 2025
Plasma proteomic and metabolomic profiling of coronary and carotid atherosclerosis in the SCAPIS study - differences and similaritiesTove Fall, Anders Gummesson, Ulf Hammar, et al.
Journal of the American Heart Association|July 3, 2024
Self-Report Tool for Identification of Individuals With Coronary Atherosclerosis: The Swedish CardioPulmonary BioImage StudyGöran Bergström, Eva Hagberg, Elias Björnson, et al.
Atherosclerosis|February 22, 2023
Body weight at age 20 and in midlife is more important than weight gain for coronary atherosclerosis: Results from SCAPISGöran Bergström, Annika Rosengren, Elin Bacsovics Brolin, et al.
The Journal of Clinical Investigation|October 5, 2013
2-Aminoadipic acid is a biomarker for diabetes riskThomas J Wang, Debby Ngo, Nikolaos Psychogios, et al.
Journal of Internal Medicine|November 17, 2022
The complexity of kidney disease and diagnosing it - cystatin C, selective glomerular hypofiltration syndromes and proteome regulationLinnea Malmgren, Carl Öberg, Emil den Bakker, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|September 1, 2025
Identification of cystatin C as a new marker of glomerular filtration rate, and of shrunken pore syndrome - a new kidney disorder defining selective glomerular hypofiltration syndromes - calls for expansion of the international KDIGO guidelinesAnna Åkesson, Carl Öberg, Linnea Malmgren, et al.
Circulation|September 20, 2021
Prevalence of Subclinical Coronary Artery Atherosclerosis in the General PopulationGöran Bergström, Margaretha Persson, Martin Adiels, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
European Journal of Heart Failure|October 28, 2024
Proteomic biomarkers and pathway analysis for progression to heart failure in three epidemiological representative cohortsAnna Dieden, Nicolas Girerd, Filip Ottosson, et al.
Nature Communications|May 22, 2015
Erratum: Distinct metabolomic signatures are associated with longevity in humansSusan Cheng, Martin G Larson, Elizabeth L McCabe, et al.
Circulation|April 13, 2012
Metabolite profiling identifies pathways associated with metabolic risk in humansSusan Cheng, Eugene P Rhee, Martin G Larson, et al.
Cardiovascular Research|May 6, 2025
Plasma proteomic and metabolomic profiling of coronary and carotid atherosclerosis in the SCAPIS study - differences and similaritiesTove Fall, Anders Gummesson, Ulf Hammar, et al.
Journal of the American Heart Association|July 3, 2024
Self-Report Tool for Identification of Individuals With Coronary Atherosclerosis: The Swedish CardioPulmonary BioImage StudyGöran Bergström, Eva Hagberg, Elias Björnson, et al.
Atherosclerosis|February 22, 2023
Body weight at age 20 and in midlife is more important than weight gain for coronary atherosclerosis: Results from SCAPISGöran Bergström, Annika Rosengren, Elin Bacsovics Brolin, et al.
The Journal of Clinical Investigation|October 5, 2013
2-Aminoadipic acid is a biomarker for diabetes riskThomas J Wang, Debby Ngo, Nikolaos Psychogios, et al.
Journal of Internal Medicine|November 17, 2022
The complexity of kidney disease and diagnosing it - cystatin C, selective glomerular hypofiltration syndromes and proteome regulationLinnea Malmgren, Carl Öberg, Emil den Bakker, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|September 1, 2025
Identification of cystatin C as a new marker of glomerular filtration rate, and of shrunken pore syndrome - a new kidney disorder defining selective glomerular hypofiltration syndromes - calls for expansion of the international KDIGO guidelinesAnna Åkesson, Carl Öberg, Linnea Malmgren, et al.
Circulation|September 20, 2021
Prevalence of Subclinical Coronary Artery Atherosclerosis in the General PopulationGöran Bergström, Margaretha Persson, Martin Adiels, et al.
Pageof 13